KWBT — Kiwa Bio-Tech Products Income Statement
0.000.00%
Last trade - 00:00
Basic MaterialsHighly SpeculativeMicro Cap
- $0.06m
- $2.88m
- $40.09m
R2015 December 31st | 2016 December 31st | 2017 December 31st | 2018 December 31st | 2019 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K/A | 10-K/A | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0 | 9.62 | 17.3 | 30.7 | 40.1 |
Cost of Revenue | |||||
Gross Profit | 0 | 2.42 | 5.42 | 8.26 | 6.92 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 0.243 | 8.75 | 15.5 | 28.1 | 41.3 |
Operating Profit | -0.243 | 0.873 | 1.8 | 2.59 | -1.19 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.428 | 1.47 | 1.92 | 2.25 | -4.98 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.428 | 1.04 | 0.842 | 0.344 | -6.64 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.677 | 0.891 | 5.31 | 0.344 | -6.64 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.677 | 0.891 | 5.31 | 0.344 | -6.64 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.214 | 0.098 | 0.067 | 0.021 | -0.19 |